About Amresco
Amresco is a Healthcare company based in Cleveland (United States) founded in 1976, and was acquired by VWR International in February 2011. It operates as a manufacturer supplier of biochemicals reagents for life science research application. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its competitors include Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
Amresco was founded in 1976 in Cleveland, United States, as a manufacturer and supplier of biochemicals and reagents. Products are provided for sectors including diagnostics, molecular biology, biotechnology, and specialty chemicals research. Standard and custom offerings cover DNA, RNA, proteins, cell culture, histology, and related biochemicals. Operations support diverse life science applications across these fields.
- Headquarters Cleveland, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website amresco-inc.com
- Social LinkedIn X Facebook
- Acquired by VWR International (Feb 2011)
- Investors
- Acquired byVWR International
(Feb 2011)
Investors in Amresco
Amresco has secured backing from 1 investor. Prominent investors backing the company include VWR International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science products and services are supplied to researchers worldwide. | 1852 | vwr.com | Radnor, United States |
Investor details for Amresco
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Amresco
2 dated milestones of Amresco across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Amresco is founded.
- Exit Acquired by VWR International.
Competitors of Amresco
Amresco has 9 listed competitors in our database, 5 of them funded. They include Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | – | 301 | Kits and reagents are developed for life science research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| biochain.com | 1994 | Hayward, United States | $7.34M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| biolamina.com | 2008 | Sundbyberg, Sweden | $18.25M | – | Recombinant laminins are produced for stem cell culture matrices. |
Detailed competitors of Amresco
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Amresco
Websites that share an audience with Amresco (amresco-inc.com).
Websites whose visitors overlap most with Amresco. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
strettonscientific.co.uk | strettonscientific.co.uk | 100% | – | – | – |
bioscience.com.cn | bioscience.com.cn | 97% | – | – | – |
| lumigen.com | 97% | – | – | View details | |
bio-world.com | bio-world.com | 95% | – | #901,632 | – |
panomics.pnnl.gov | panomics.pnnl.gov | 88% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Amresco
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Amresco (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amresco
Complete news archive for Amresco
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amresco
Amresco was founded in 1976.
Amresco is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
Amresco was founded in 1976 in Cleveland, United States, as a manufacturer and supplier of biochemicals and reagents. Products are provided for sectors including diagnostics, molecular biology, biotechnology, and specialty chemicals research. Standard and custom offerings cover DNA, RNA, proteins, cell culture, histology, and related biochemicals. Operations support diverse life science applications across these fields.
Amresco's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Amresco has 1 investor. Key investors include VWR International.
Yes. Amresco was acquired by VWR International in February 2011.